Printer Friendly

Articles from United Kingdom Pharmaceuticals (May 7, 2019)

1-13 out of 13 article(s)
Title Author Type Words
Amgen UK (NYSE: AMGN). 2265
AstraZeneca (NYSE: AZN). 13298
AstraZeneca - Qternmet XR approved in the US for the treatment of type-2 diabetes -- 3/5/2019. 164
Bristol Myers Squibb UK. 1912
Eisai Europe - Eisai Buys Out Purdue Rights To End Collaboration -- 1/5/2019. 218
Eisai Europe. 816
Eli Lilly and Company UK (NYSE: LLY) - Lilly to Present New Data at AAN 2019 on Emgality[R] (galcanezumabgnlm) and Lasmiditan Reinforcing Breadth of Headache Disorders Portfolio -- 2/5/2019. 367
GlaxoSmithKline (LSE: GSK) - Phase III CAPTAIN study of Trelegy Ellipta in patients with asthma meets primary endpoint -- 2/5/2019. 422
Merial UK. 362
Pfizer UK. 4157
Roche Products UK. 207
Shire plc UK (LSE: SHP, NASDAQ: SHPG). 3748
The Industry. 535

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters